This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ransheng Ding: Innovator in Aryl Aminopyrimidines
Introduction
Ransheng Ding is a notable inventor based in Binhai New District, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific kinase activities.
Latest Patents
One of his key patents is titled "Aryl aminopyrimidines as dual MerTK and TYRO3 inhibitors and methods thereof." This patent discloses aminopyrimidine-containing compounds that inhibit both Mer tyrosine kinase (MerTK) activity and Tyro3 kinase activity. The patent also outlines methods for synthesizing and utilizing these compounds as anti-cancer agents, immunostimulatory and immunomodulatory agents, anti-platelet agents, and anti-infective agents.
Career Highlights
Ransheng Ding is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance his research in the field. His work has led to the development of innovative therapeutic agents that hold promise for various medical applications.
Collaborations
He has collaborated with notable colleagues, including Xiaodong Wang and Yubai Zhou, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ransheng Ding's work in developing aminopyrimidine compounds showcases his commitment to advancing medical science and improving therapeutic options. His contributions are paving the way for future innovations in cancer treatment and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile